A6R-18023-90853
2 vaccinations
2 coded responses
4 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 380 / TN
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
-
2021-03-30
Survey response — day 14, dose 1MedDRA: Fatigue, Heart rate increased — Feeling: Good · Be unable to do your normal daily activitiesFree text: I had increased heart rate up to 145 bpm for more than 2 hours on 03/30/2021. New problem and I have never had this type of sustained elevated heart rate. Felt fatigue after the 1st hour and apple watch notification of HR more than 110 for sometime.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Dose 2 — Pfizer-BioNTech
- 2021-04-12
- 2021-04-19
-
2021-07-05
Survey response — 3 months, dose 2MedDRA: Dizziness, Dizziness exertional, Heart rate increased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: On 6/23 Episodic tachycardia with sustained heart rate between 140-155 ish. Self-limiting with dissipation after about 3.5 hours. Dizziness experienced upon movement or ambulation. No difficulty breathing but felt lightheaded when changing position.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech |
Free text
Release 6 — day 14, dose 1
Symptoms: I had increased heart rate up to 145 bpm for more than 2 hours on 03/30/2021. New problem and I have never had this type of sustained elevated heart rate. Felt fatigue after the 1st hour and apple watch notification of HR more than 110 for sometime. cut off by CDC
Release 9 — 3 months, dose 2
Symptoms: On 6/23 Episodic tachycardia with sustained heart rate between 140-155 ish. Self-limiting with dissipation after about 3.5 hours. Dizziness experienced upon movement or ambulation. No difficulty breathing but felt lightheaded when changing position. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dizziness exertional | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release